Information given in response to FOI request

Queen Mary, University of London - FOI Request: 2013/F42

Information provided by Queen Mary, University of London, in response to a freedom of information request, in relation to the PACE trial [1,2].

PACE Trial

Normal Range at Baseline

Proportion of participants at baseline within ‘normal range’ for Chalder fatigue and SF-36 physical function.

Relevant Correspondence:

Dear Mr. Smallcombe,

Thank you very much for your reply. It appears that I did not ask my question well enough however. Would it be possible to ask how many participants were in the normal range in either the SF-36 or Chalder Fatigue Scale at the beginning of the trial, ie one or the other?

Thank you very much for your time.

Regards,

<name>

(Queen Mary, University of London) FOI Request: 2013/F42

On Mon, Mar 11, 2013, <foi-enquiries@qmul.ac.uk> wrote:

Dear <name>

Thank you for your email of 12th February.

Please see the attached for the information you requested.

If you are dissatisfied with this response, you may ask the College to conduct a review of this decision. To do this, please contact the College in writing (including by fax, letter or email), describe the original request, explain your grounds for dissatisfaction, and include an address for correspondence. You have 40 working days from receipt of this communication to submit a review request. When the review process has been completed, if you are still dissatisfied, you may ask the Information Commissioner to intervene. Please see www.ico.gov.uk for details.

Yours sincerely

Paul Smallcombe

Records & Information Compliance Manager

References

PACE Trial:

1. White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, Bavinton J, Angus BJ, Murphy G, Murphy M, O'Dowd H, Wilks D, McCrone P, Chalder T, Sharpe M; PACE trial management group.

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial.

Lancet. 2011;377:823-36.

doi:10.1016/S0140-6736(11)60096-2

2. White PD, Goldsmith K, Johnson AL, Chalder T, Sharpe M.

Recovery from chronic fatigue syndrome after treatments given in the PACE trial.

Psychol Med. 2013;43:2227-35.

Tags:

Proportion achieving normal range values for SF36 and CFQ at baseline

CBT GET APT SMC